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The embryonic Stem cell Test (EST) is a validated assay for testing embryotoxicity in vitro. The total duration of this protocol is 10
days, and its main end-point is based on histological determinations. It is suggested that improvements on EST must be focused
toward molecular end-points and, if possible, to reduce the total assay duration. Five days of exposure of D3 cells in monolayers
under spontaneous diﬀerentiation to 50ng/mL of the strong embryotoxic 5-ﬂuorouracil or to 75μg/mL of the weak embryotoxic
5,5-diphenylhydeantoin caused between 20 and 74% of reductions in the expression of the following genes: Pnpla6, Afp, Hdac7,
Vegfa,a n dNes. The exposure to 1mg/mL of nonembryotoxic saccharin only caused statistically signiﬁcant reductions in the
expression of Nes. These exposures reduced cell viability of D3 cells by 15, 28, and 34%. We applied these records to the mathe-
matical discriminating function of the EST method to ﬁnd that this approach is able to correctly predict the embryotoxicity of
all three above-mentioned chemicals. Therefore, this work proposes the possibility of improve EST by reducing its total duration
and by introducing gene expression as biomarker of diﬀerentiation, which might be very interesting for in vitro risk assessment
embryotoxicity.
1.Introduction
Toxicity to reproduction has to be mandatorily assessed in
developed countries for the registration and authorization
of all chemicals with medium and high production vol-
umes. Toxicity to reproduction includes adverse eﬀects of
chemicals on fertility, embryotoxicity, teratogenicity, and
development.OECDhasitsowninvivoguidelinesfortesting
either teratogenicity (OECD 414) or toxicity to reproduc-
tion (testing simultaneously all the above-stated adverse
eﬀects) by performing two generation toxicity assays (OECD
416) [1]. It seems remarkable that there are no in vivo guide-
lines for testing embryotoxicity, which has to be assayed in
OECD guideline 416 [2]. Assays according to OECD-416
guideline are time consuming and expensive as they involve
lots of animals. It is estimated that one assay of this kind
to test a single chemical requires 3200 animals [3]w i t ha n
estimated cost of more than C300000 [4]. Thus, it is obvious
that a fast, safe, and reliable in vitro alternative method for
performing embryotoxicity risk assessment would be wel-
comed by industry. Furthermore, it would help to save lots
of resources devoted to test other toxicity to reproduction
eﬀects accounting after embryonic development, which is
especially relevant for the massive screenings performed
during the early development stages of chemicals for lots
of purposes (i.e., pharmaceuticals, cosmetics, biocides, food
additives, etc.).
The only validated methods available for testing embry-
otoxicity in vitro are the embryonic stem cell test (EST) (see
abbreviations), the mouse whole embryo culture, and the
micromass method. Of these, EST is the only “pure” in vitro
method because it totally suppresses the use of animals [2].
EST uses two mouse cell lines, D3 embryonic stem cells for
testing embryotoxicity by monitoring general cytotoxicity
and disturbances in their diﬀerentiation, and 3T3 ﬁbroblasts
embryonic cells for testing general cytotoxicity in a non-
diﬀerentiating system. EST uses three diﬀerent end-points,
IC50D3 and IC503T3, which are deﬁned as the concentration2 Journal of Toxicology
of the tested chemical that causes 50% reduction in the via-
bility of D3 and 3T3 cells, respectively, and ID50,d e ﬁ n e da s
the concentration of the tested chemical that causes inhibi-
tion of D3 cells diﬀerentiation by 50% [5]. These three end-
points are further integrated into three linear discriminant
functions which discriminate the embryotoxic potential of
chemicals into three categories: non, weak, and strong em-
bryotoxicity [6].
EST is relatively lengthy because it requires the exposure
of cells to tested chemicals for 10 days. Its technical com-
plexity is also relatively high because it includes cell cultures
in monolayers to obtain IC50D3 and IC503T3 through
cytotoxicity assays, as well as the culture of “hanging drop”
embryoid bodies (EBs) for testing alterations in the dif-
ferentiation of D3 cells. EST is also laborious because it
entails two changes of culture medium (of three diﬀerent
cultures containing the two diﬀerent cell lines), which are
speciﬁcally prepared with all 6–8 diﬀerent concentrations of
the tested chemical. Besides, more than 300EBs per single
test have to be individually seeded and further optically
analyzed. Additionally, a main weakness of EST is the need
to monitor changes in the D3 EBs diﬀerentiation caused by
exposure to the assessed chemical. Indeed, it is performed
by an individual microscopic inspection of the 10-day diﬀer-
entiated EBs to determine if they are contractile, or not,
withoutconsidering otherrelevantcircumstancessuchasthe
total beating area.
Despite the above-stated drawbacks, EST has overcome
a blind interlaboratory validation study sponsored by the
European Centre for Validation of Alternative Methods
(ECVAM) that considers EST ready for the in vitro screening
embryotoxicity of chemicals [7]. However, ECVAM also con-
siders that EST is still not ready for regulatory purposes and
that its performance has to be improved by adopting several
approaches. In this way, some of ECVAM’s suggestions to
be implemented in the EST protocol [8] are to introduce
molecular end-points (for a better quantiﬁcation of D3 cells
diﬀerentiation) and to introduce end-points for monitoring
thediﬀerentiationtothethreemainembryoniclineages(and
not only mesoderm-derived cardiomyocytes).
In this work, we followed ECVAM’s suggestions by using
the expression of several genes deriving from mesoderm,
endoderm, and ectoderm as biomarkers of diﬀerentiation.
We used these biomarkers to estimate ID50 based on molecu-
larapproaches.Wefoundthatthelineardiscriminatingfunc-
tionsoriginatingfromtheESTprotocolwereabletocorrectly
predict the embryotoxicity of the strong embryotoxic chem-
ical 5-ﬂuorouracil (5-FU), the weak embryotoxic chemical
5,5-diphenylhydantoin (DPH), and the nonembryotoxic
chemical saccharin. We also proposed other improvements
totheESTprotocolbyemployingmonolayerculturesinstead
of hanging drops EBs and by cutting the exposure time from
1 0d a y st o5d a y s .
2.MaterialsandMethods
2.1. Cell Cultures. D3 cells were grown on monolayers in un-
diﬀerentiated state on 75-mm plates in Dulbecco’s modiﬁed
eagle medium (DMEM), medium supplemented with 15%
heat-inactivated fetal bovine serum, 1% nonessential amino
acids, 50 units of penicillin/mL, 100μg streptomycin/mL,
0.1mMβ-mercaptoethanol,and1000unitsofleukemiainhi-
bition factor(LIF)/mL.Undiﬀerentiated cellswereincubated
at37◦Ci na na tm o s p h e r ewi t h1 . 5 %C O 2 and 95% humidity.
ForculturingD3cellsunderspontaneousdiﬀerentiation,LIF
was removed from the medium culture, and the CO2
concentration was increased to 5%.
3 T 3c e l l sw e r eg r o w no nm o n o l a y e r so n7 5 m mp l a t e s
in DMEM medium supplemented with 10% calf serum, 50
units of penicillin/mL, and 100μg streptomycin/mL. Cells
were incubated at 37◦Ci na na t m o s p h e r ew i t h5 %C O 2 and
95% humidity.
2.2. Cellular Exposures to Chemicals. Fresh 5-FU, DPH, or
saccharin were added to the medium cultures at the appro-
priate concentrations just before starting exposures. D3 cells
under spontaneous diﬀerentiation were cultured for 5 days
on monolayers in P100 Petri dishes (for gene expression
monitoring) or in 96-well plates (for cytotoxicity assays) as
stated above. 3T3 cells were cultured in 96-well plates as
described above and were also exposed to 5-FU, DPH, or
saccharin for 5 days. In all cases, the culture medium was
c h a n g e do nd a y3o fe x p o s u r e .
2.3. Cytotoxicity Assays. The cytotoxicity caused by exposure
to 5-FU, DPH, and saccharin was assayed with the
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbrom-
ide (MTT) assay, which is the cytotoxicity assay used in
the EST protocol [6]. This test is based on the ability of
mitochondrial dehydrogenases to convert the yellow sub-
strate MTT into a dark blue formazan product.
D3 and 3T3 cells were seeded at 20000cells/well and
incubated as described above in the presence of diﬀerent
5-FU, DPH, or saccharin concentrations. On day 5 of expo-
sure, chemicals were removed, and cells were incubated with
1mg MTT/mL for 3 hours. At the end of this period, MTT
was removed, and cells were washed with phosphate buﬀer
saline. Finally, 100μL of dimethyl sulfoxide/well were added
to lysate cells, and the generated formazan was monitored
recording absorbance at 570nm. It was assumed that control
cultures (not exposed to 5-FU, DPH, or saccharin) presented
maximum viability, and the results were expressed as a per-
centage as regards these controls. Each condition was assayed
in 12 independent wells.
2.4. Quantiﬁcation of the Gene Expression. The expression of
the genes proposed as biomarkers of diﬀerentiation was
recorded by quantitative RT-PCR with three independent
plates per assayed condition.
Cell cultures were trypsinized after exposure to 5-FU,
DPH,orsaccharin,andtotalRNAwasextractedwithTripure
according to Chomczynski and Sacchi [9]. RNA was quan-
tiﬁed and purity determined according to the 260/280nm
optical density ratio. One μg of RNA was reverse transcribed
using Expand Reverse Transcriptase and oligo-dT primers
(Roche) according to the manufacturer’s recommendations.
All the genes (except Pnpla6) were assayed using the
Light Cycler Fast Start DNA Master PLUS SYBR Green IJournal of Toxicology 3
Table 1: Primer sequences and annealing temperatures used in the quantitative RT-PCR experiments.
Gene 5
 –3
  oligo 3
 –5
  oligo T (◦C)
Actin CCCTAGGCACCAGGGTGTGA TCCCAGTTGGTAACAATGCCA 62
Afp GCTGCAAAGCTGACAACAAG GGTTGTTGCCTGGAGGTTTC 63
Vegfa CGTTCACTGTGAGCCTTGTTCAG GCCTTGCAACGCGAGTCTGT 60
Hdac7 CCATGTTTCTGCCAAATGTTTTGG GCCGTGAGGTCATGTCCACC 63
Flk1 CAGCCAGACAGACAGTGGGATGGTC CCGAGGCCACAGACTCCCTGCTT 61
Nes GCTTTCCTGACCCCAAGCTG GGCAAGGGGGAAGAGAAGGA 61
Table 2: The linear discriminant functions and classiﬁcation criteria considered in EST for assessing the embryotoxicity potential of
chemicals. Data taken from [11]. IC50D3 was deﬁned as the concentration that reduces the viability of D3 cells by 50% after 10 days of
exposure. IC503T3 was deﬁned as the concentration that reduces the viability of 3T3 cells by 50% after 10 days of exposure. ID50 was deﬁned
as the concentration that inhibits the spontaneous diﬀerentiation of D3 embryoid bodies to contractile cardiomyocytes by 50%. IC50D3,
IC503T3, and ID50 must necessarily be expressed in μg/mL.
I = 5.916log(IC503T3) + 3.500log(IC50D3) − 5.307[(IC503T3 − ID50)/IC503T3] − 15.27
II = 3.651log(IC503T3) + 2.394log(IC50D3) − 2.033[(IC503T3 − ID50)/IC503T3] − 6.85
III = −0.125log(IC503T3) − 1.917log(IC50D3) + 1.500[(IC503T3 − ID50)/IC503T3] − 2.67
Strong embryotoxic if Weak embryotoxic if Non embryotoxic if
III > I and III > II II > Ia n dI I> III I > II and I > III
kit (Roche). The PCR program consisted in an initial step
at 95◦C for 10 minutes followed by 40 cycles of 10 seconds
denaturing at 95◦C, 7 seconds at the respective annealing
temperature, and 12 seconds at 72◦C, plus a ﬁnal melting
curve step. Table 1 indicates the primer sequences and the
annealing temperatures employed for each gene. The Pnpla6
expression was monitored in the samples analyzed with the
speciﬁc Taqman kit supplied by Applied Biosystems.
Quantiﬁcation was performed by considering 2(−ΔΔCt)
calculations[10]withtheStep-Onesoftware,v2.0.1(Applied
Biosystem). β-Actin was used as an invariant internal control
for each sample.
2.5. Results Validation. The performance of the proposed
end-points was validated by applying the same linear dis-
criminant functions and by following the classiﬁcation cri-
teria used in the EST protocol. These functions and criteria
are summarized in Table 2.
2.6. Statistical Signiﬁcance. Diﬀerences between the gene ex-
pression of the control and chemical-exposed cultures were
statistically analyzed with Student’s t-tests performed with
Graph-Pad Instat (v 3.06). The level of signiﬁcance (P)i s
indicated in each case.
3. Results
3.1. Cytotoxicity of 5-FU, DPH, and Saccharin. The cytotox-
icity caused by 5-FU, DPH, and saccharin after 5 days of
exposure to D3 and 3T3 cells was assayed with the MTT test
since these end-points are required to assay embryotoxicity
according to EST. 5-FU was more toxic for D3 cells than for
3T3 cells (Figure 1(a)). IC50D3 was 0.17μg/mL, while IC50
for3T3cellswasrecordedtobe2.6timeshigher(Table3).We
chose the 50ng/mL concentration to test the eﬀect of 5-FU
o ns e v e r a lb i o m a r k e r so fd i ﬀerentiation which, according to
Figure 1(a), would cause a reduction of the viability for D3
and 3T3 cells by 15% and 6%, respectively.
On the opposite to 5-FU, the cytotoxicity of DPH was
higher (1.4 times) for 3T3 than for D3 cells (Figure 1(b),
Table 3). We studied gene expression on D3 cells exposed
for 5 days to 75μg DPH/mL, which according to Figure 1(b)
wouldcauselossofviabilityof28%.Theestimatedreduction
of 3T3 cell viability caused by this exposure was 38%.
The IC50 for D3 and 3T3 cells of saccharin were both
higher than 1000μg/mL (Figure 1(c),T a b l e3). This concen-
tration (1000μg/mL) was used for testing negative controls
in the standard EST tests and was selected for testing its
eﬀects on gene expression of D3 cells under spontaneous dif-
ferentiation.
3.2. Expression of Gene Markers of Diﬀerentiation on D3 Cells
Exposed to 5-FU, DPH, and Saccharin. We assayed the ex-
pression of several genes considered useful as biomarkers of
diﬀerentiation to propose molecular end-points for moni-
toring the changes taking place in the process as a result of
exposure to embryotoxic chemicals, which would potentially
improve the microscopic observation of beating EBs. We
found(Figure2(a))thattheexposureofD3cellsunderspon-
taneousdiﬀerentiationto50ng5-FU/mLfor5daysinhibited
the expression of patatin-like phospholipase domain con-
taining 6 (Pnpla6), α-fetoprotein (Afp), histone deacetylase
7( Hdac7), vascular endothelial growth factor A (Vegfa), and
nestin (Nes) by 20, 74, 50, 54, and 46%, respectively. It is also
remarkable to note that the expression of fetal liver kinase
1( Flk1) was also altered but, in this case, we detected an
increase in the expression of 2.2 times (Figure 2(a)) instead
of inhibition. In all cases, the changes in the expression were
statistically signiﬁcant (Figure 2(a)). Thus, we can estimate
that the 5-FU concentrations causing a 50% reduction in4 Journal of Toxicology
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Figure 1: Eﬀect of 5-FU, DPH, and saccharin on cell viability. D3 and 3T3 cells were cultured on monolayers exposed to 5-FU (a), DPH
(b), or saccharin (c) for 5 days. Then the MTT test was performed as described in Section 2. D3 cells were cultured under spontaneous
diﬀerentiation (in the absence of LIF). The results are expressed as a percentage of absorbance at 570nm with regards to the control cultures,
which were not exposed to 5-FU, DPH, or saccharin. Each condition was assayed with twelve independent wells.
the expression of the assayed biomarkers (which could be
considered the equivalent to the ID50 end-point in EST)
would be around 50ng/mL for Hdac7, Vegfa,a n dNes, higher
(but in the same order of magnitude) than 50ng/mL for
Pnpla6 and lower than 50ng/mL for Afp (Figure 2,T a b l e3).
T h ee x p o s u r e( 5d a y st o7 5μg/mL) to DPH of D3 diﬀer-
entiating cells reduced the expression of Pnpla6, Afp, Hdac
7, Vegfa,a n dNes to 89, 48, 74, 56, and 48%, respectively,
of nonexposed diﬀerentiating cells (Figure 2(b)). DPH also
increased expression of Flk 1 in a similar extension (2.1
times) as 5-FU did (Figure 2(b)). These changes in the gene
expression were all statistically signiﬁcant except for Pnpla6
and Hdac7. These records allow estimating that concentra-
tions of DPH causing reduction of 50% in the expression of
Afp, Nes,a n dVegfa would be around 75μg/mL, and slightly
higher for Pnpla6 and Hdac7.
The exposure of D3 cells to 1000μgsaccharin/mL during
5 days causes no signiﬁcant alterations in the expression
of Pnpla6, Vegfa,a n dFlk1, reductions in the expression of
Hdac7 (26%) and Nes (49%), and a strong increase (4.4
times) in the expression of Afp (Figure 2(c)).
3.3. Tested Biomarkers Ability to Assign Embryotoxic Potential.
We validated the expression of our biomarker genes as
regards their ability to detect and classify embryotoxic chem-
icals using the same linear discriminant functions employed
in EST with ID50 as the 5-FU, DPH, and saccharin concen-
trations which inhibit the expression of the gene by 50%
(Table 3). We found that Pnpla6, Afp, Vegfa, Hdac7,a n dNes
were able to assign the label of strong embryotoxicant to 5-
FU and weak embryotoxicant to DPH, in accordance with
its in vivo toxicity, and also as was previously reported
with standard EST [5]. Pnpla6, Flk1, Vegfa, Hdac7,a n dNes
also properly labeled saccharin as nonembryotoxic chemical
(Table 3).
4. Discussion
We tested the expression of the biomarker genes of early
diﬀerentiation as possible end-points to improve EST per-
formance. At the same time, we proposed a reduction in
the total test duration and a simpliﬁcation of the process
since we used monolayer cultures instead of “hanging drops”Journal of Toxicology 5
Table 3: Biomarkers validation. The capability of the tested biomarkers to assign an embryotoxic potential to chemicals was validated using
thelineardiscriminatefunctionsandtheESTprotocolcriteriaaccordingtowhatTable2displays.IC50D3andID503T3recordswereobtained
from Figure 1, while ID50 was obtained from Figure 2.
IC50D3 ID503T3 ID50 Linear discriminant functions
Substance Gene (μg/mL) (μg/mL) (μg/mL) I II III CLA
5-FU
Pnpla6 0.17 0.44 >0.05 −25 + 12ID50 −12 + 4.6ID50 0.37 − 3.4ID50 S
Afp 0.17 0.44 <0.05 −25 + 12ID50 −12 + 4.6ID50 0.37 − 3.4ID50 S
Hdac7, Vegfa, Nes 0.17 0.44 0.050 −25 −12 0.18 S
Flk1 0.17 0.44 NA — — — NA
DPH
Nes, Vegfa, Afp 130 97 75 2.6 5.0 −6.6 W
Pnpla6, Hdac7 130 97 >75 −1.4 + 0.05ID50 3.5 + 0.02ID50 −5.5 − 0.02ID50 W
Flk1 130 97 NA — — — NA
Saccharin
Nes 1850 1640 1000 13 12 −8 NON
Pnpla6, Hdac7,
Vegfa, Flk1, Nes 1850 1640 >1000 10 + 0.003ID50 11 + 0.001ID50
−7.8 −
0.0008ID50
NON
Afp 1850 1640 NA — — — NA
CLA: classiﬁcation of embryotoxicity; S: strong embryotoxicant; W: weak embryotoxicant; NON: nonembryotoxicant; NA: not applicable.
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Figure 2:Eﬀectof5-FU,DPH,andsaccharinonD3diﬀerentiation.MonolayerculturesofD3cellsunderspontaneousdiﬀerentiation(inthe
absence of LIF) were exposed to either 50ng5-FU/mL (a), or 75μg DPH/mL (b), or 1000μg saccharin/mL (c) over 5 days. When exposure
ended, RNA was extracted, and the gene expression of the biomarkers of diﬀerentiation was assayed by quantitative RT-PCR according to
the procedure described in Section 2. The gene expression was expressed as a percentage as regards the control cultures (not exposed to
chemicals). Each condition (control and exposed cultures) was assayed in three independent plates. (∗: statistically diﬀerent from controls
for P < 0.05; ∗∗: statistically diﬀerent from controls for P < 0.01).6 Journal of Toxicology
EBs. The implementation of changes to EST would reﬁne
its predictability and allow its future use for regulatory
purposes, which would prove useful for the risk assessment
ofembryotoxicity,andsubsequentlyfortoxicitytoreproduc-
tion.
4.1. Cytotoxicity. We found that 5-FU was 2.6 times more
toxic to D3 cells than to 3T3 cells (Table 3), which was
expected since 5-FU was classiﬁed as a strong embryotox-
icant. These results are comparable to those found in the
EST validation study sponsored by ECVAM, where 5-FU was
f o u n dt ob e3 . 3t i m e sm o r et o x i cf o rD 3c e l l st h a nf o r3 T 3
cells [6]. This slight diﬀerence can be justiﬁed on the basis of
diﬀerences in the exposure (10 days in the case of the EST
validation study and 5 days in our work). This diﬀerence
also justiﬁes that our recorded IC50 was 1.8 and 1.5 times
higher for D3 and 3T3, respectively, than the values recorded
with the standard EST protocol [6]. The IC50 found in this
studyfor3T3cellsexposedtoDPHwas1.7timeshigherthan
the record obtained in the ECVAM’s EST validation study
[6], which is in concordance with diﬀerences found in the
case of 5-FU. The cytotoxicity records found for D3 and 3T3
cellsexposedtosaccharinwerealsoconsistentwithpublished
resultsbecausewealsofoundﬁgureshigherthan1000μg/mL
[6].
4.2. Expression of Biomarkers of Diﬀerentiation. Pnpla6 is the
gene that codiﬁes for a protein called neuropathy target
esterase (NTE). NTE is a target of a neurodegenerative
syndrome caused by certain organophosphorus pesticides.
Additionally, homozygous NTE−/− mice embryos were not
viable due to failures in vasculogenesis [12], and although
heterozygous NTE+/− mice embryos were viable, the result-
ing animals displayed alterations in the nervous system [13].
We previously reported that Pnpla6 is expressed constitu-
tively in D3 cells although a peak in expression is reached
in initial diﬀerentiation stages [14]. All these data indicate
that Pnpla6 may play critical roles in normal nervous system
development (ectoderm-derived tissue) and blood vessels
(endoderm-derived tissues), suggesting that this gene is a
good candidate to be used as a biomarker of early diﬀer-
entiation. We found that 5-FU and DPH caused reductions
(statistically signiﬁcant in the case of 5-FU) in the expression
of Pnpla6 under our assay conditions (Figures 2(a) and
2(b)), indicating that Pnpla6 might be used for detecting
exposure to embryotoxic chemicals by monitoring changes
in diﬀerentiation.
Afp is typically considered a biomarker of the visceral
endoderm [15]. Exposure of D3 cells under diﬀerentiation
to 50ng5-FU/mL and to 75μg DPH/mL inhibited the Afp
expression by 74% (Figure 2(a)) and 52% (Figure 2(b)),
respectively, which suggests that Afp is a very sensitive bio-
marker of exposure to embryotoxicants. These results are
supported by other previous reports which found that the
expression of this gene was inhibited in 20-day-old EBs
exposed to 5-FU concentrations several orders of magnitude
lower than IC50 [16]. In our case, we have demonstrated that
Afp’s sensitivity as a biomarker is maintained, even only after
5d a y so fd i ﬀerentiation.
Vegfa and Hdac7 are considered endoderm biomarkers
since the former is involved in the vasculogenesis of yolk
sac and hematopoiesis [17], while the latter is implicated
in vasculogenesis, endothelial cells migration, and vascular
integritymaintenance[18].Theexpressionofbothgeneswas
inhibited by around 50% after 5 days of exposure to 5-FU or
DPH (Figures 2(a) and 2(b)), suggesting that both genes can
be used for our purposes. The expression of Vegfa has also
been previously proposed as a molecular end-point for EST
[19],althoughinourcase,wecuttheexposuretimebyhalfto
demonstratethatthegenemaintainsitsgoodperformanceas
a biomarker of diﬀerentiation. To our knowledge, this is the
ﬁrst proposal of Hdac7 as a biomarker of diﬀerentiation to
be used in EST.
Nes codiﬁes for neuroﬁlament proteins and, therefore,
plays a critical role in maintaining cellular integrity [20]. We
found a statistically signiﬁcant reduction in the expression of
Nes as a result of cell exposure to 5-FU, DPH, and saccharin
(Figure 2), which indicates that Nes might be a good bio-
marker of exposure to embryotoxicants, at least in D3 cells,
as they displayed good compromise in diﬀerentiation toward
the neuroectoderm when cultured in monolayers [21].
Flk1 is an early mesodermal biomarker [22], which is
also altered by 5-FU exposure (Figure 2). However, unlike
other assayed biomarkers, 5-FU and DPH led to increases
of expression instead of inhibitions (Figures 2(a) and 2(b)),
which means that Flk1 is unsuitable for use in accordance
with the EST approach since its mathematical discriminant
function was developed considering end-points which were
underexpressed as regards the control and not overexpressed
as in Flk1 in our study. Nevertheless, changes in the exp-
ression of Flk1 were statistically signiﬁcant, and this infor-
mation can be valuable as it complements the information
obtained for other biomarkers.
4.3. Performance of Biomarkers for Discrimination of Embry-
otoxicant Potency. 5-FU is a well-known in vivo embryotoxic
agent that has been labeled by EST as a strong embryotoxi-
cant (it is included as a positive control in the standard EST
protocol). We applied the mathematical functions of EST to
our results by considering ID50 as the value of the 5-FU con-
centration that inhibited the expression of each biomarker
by 50% to determine if our proposed approach yields
the same results as the standard protocol. We found that
Vegfa, Hdac7,a n dNes predicted that 5-FU was a strong
embryotoxicant (function III > function I and function III >
function II) (Table 3). We could not estimate ID50 for Pnpla6
but, according to Figure 2(a), we can establish that it is
higher than 50ng/mL. The analysis done of the discriminant
functions with the available data demonstrated that the
conditions to be labeled as strong embryotoxic (function III
> function I and function III > function II) were lost only
for an ID50 higher than 1.5μg/mL. Figure 1(a) illustrates that
this exposure would cause total loss of the viability of both
the D3 and 3T3 cells, therefore suggesting that if ID50 for
Pnpla6 was determined, then 5-FU would also be labeled
as a strong embryotoxicant. The ID50 for Afp could not be
determined with the available data, but it is concluded that it
must be lower than 50ng/mL (Figure 2(a)). However, withJournal of Toxicology 7
the available information, the analysis of the discriminant
functions once again demonstrated that if ID50 < 50ng/mL,
then necessarily III > II and III > I; therefore, 5-FU was
correctly classiﬁed as a strong embryotoxicant when using
Afp as a biomarker of diﬀerentiation.
DPH is a well-known in vivo embryotoxic agent that has
been labeled by EST as a weak embryotoxicant. When we
applied the above-explained approach, we found that in the
case of Nes, Vegfa,a n dAfp, function II was always higher
than functions I and II (Table 3), which led to necessarily
classify DPH as weak embryotoxicant as EST does. The DPH
concentrations with capability to inhibit 50% of the expres-
sion of Pnpla6 and Hdac7 could not be exactly estimated
but according to Figure 2(b) should be in the same order
of magnitude as 75μg/mL, which according to IC50 records
yields the functions I, II, and III as was stated in Table 3.
In this situation and taking into consideration that ID50
should necessarily be positive, II always will be higher than
III, and II will be higher than I (the needed condition to label
DPH as weak embryotoxicant) for ID50 < 143μg/mL, which
is compatible with data displayed in Figure 2(b) where we
demonstrated that 75μgDPH/mL was able to inhibit 11 and
26% of Pnpla6 and Hdac7 expression, respectively.
The expression of Nes was inhibited by 50% by the expo-
sure to 1000μgsaccharin/mL (Figure 2(c)). Considering the
records for IC50, we found that saccharin must be classiﬁed
as nonembryotoxicant, since I > II and I > III (Table 3).
We also found that ID50 for Pnpla6, Hdac7, Vegfa, Flk1,
and Nes was always higher than 1000μgsaccharin/mL, which
becomes EST discriminant functions in equations showed in
Table 3. Considering that ID50 must be necessarily positive,
it supposes that I will be always higher than III and higher
than II for ID50 higher than 420μg/mL, which is consistent
to results shown in Figure 2(c) and led to necessarily classify
saccharin as nonembryotoxicant, as was established by the
EST method.
5. Conclusions
We propose implementing the expression of 6 diﬀerent
biomarkers of diﬀerentiation to EST end-points, which
would improve the performance of this method for risk
assessment (speciﬁcally in the step of hazard identiﬁcation).
Thesebiomarkershavesuccessfullypredictedtheembryoto x-
icity of 5-FU, DPH, and saccharin, but an assessment with
another embryotoxicant chemicals is pending. In addition,
we introduced three other improvements: reducing the total
test time by half, employing monolayer cultures instead of
more technically complex techniques to manage EBs, and
the possibility to assess several end-points (the expression of
several genes) for the same exposed cells.
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